MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
BRCA gene mutations in cancer
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,673 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,673 works in the cohort · of 4,299,418page 22 of 54

Labels cover 9 of 2,673 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,673 of 2,673 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Health-related quality of life (HRQOL) and patient-centered outcomes with maintenance olaparib compared with placebo following chemotherapy in patients with germline (g) BRCA-mutated (m) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): SOLO2 phase III trial.
Michael Friedländer, Val Gebski, Emma Gibbs, Ralph Bloomfield, Felix Hilpert, Lari Wenzel +14 more
2017· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
18
citations
affaboutunlabeled
Genetic Counselors’ and Genetic Counseling Students’ Attitudes Around the Clinical Doctorate and Other Advanced Educational Options for Genetic Counselors: A Report from the Genetic Counseling Advanced Degree Task Force
Rebecca J. Nagy, Holly L. Peay, Melissa A. Hicks, Jacqueline Kloos, Rachel Westman, Laura Conway +8 more
2014· article· en· Journal of Genetic Counseling· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
18
citations
fundno affunlabeled
Combining Breast Cancer Risk Prediction Models
Zoe Guan, Theodore Huang, Anne Marie McCarthy, Kevin S. Hughes, Alan Semine, Hajime Uno +3 more
2023· article· en· Cancers· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
18
citations
affunlabeled
BRCA2 Variants and cardiovascular disease in a multi-ethnic study
Kevin Zbuk, Changchun Xie, Robin Young, Mahyar Heydarpour, Guillaume Paré, A. Darlene Davis +8 more
2012· review· en· BMC Medical Genetics· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
18
citations
affno abstractunlabeled
Survival from breast cancer in patients with CHEK2 mutations
Tomasz Huzarski, Cezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, Tomasz Byrski, Jacek Gronwald +13 more
2014· article· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
17
citations

How this was built: Screen · Findings · About